← All peptides

9-Me-BC (9-Methyl-β-carboline)

Research Use Only
capsuleOral

A unique brain booster that enhances your dopamine system, promotes the growth of new nerve branches, and may even help regenerate dopamine-producing brain cells. Unlike most cognitive enhancers, it works through a completely different mechanism. Important: you need to avoid sun and UV exposure while using it.

What to Expect

1

Week 1–2

Enhanced dopaminergic function — improved motivation, focus, and mood. Increased mental energy. Subtle cognitive enhancement.

2

Week 3–6

Sustained dopamine system upregulation. Improved neuroplasticity. Better cognitive performance. Enhanced exercise motivation and drive.

3

Week 8+

Potential neuroprotective effects on dopaminergic neurons. Long-term safety data is very limited — extreme caution advised.

Common Side Effects

Photosensitivity (avoid UV/sun exposure)Insomnia if dosed lateIrritabilityDNA damage risk with UV exposureVery limited safety data
Tolerance: Unknown — limited human data
Cycling: 2-4 weeks on, 4+ weeks off. Avoid sun/UV exposure during use. Highly experimental — limited safety data.

Dosing

15-30 mg by mouth daily. Stay out of sunlight and UV light while taking it. Cycle for 2-4 weeks max.

Practical Guide

Storage

Store capsules/powder in dark container at room temperature. Protect from light (photosensitive compound).

Timing

Morning dosing only — dopaminergic effects can disrupt sleep. Strictly avoid sun/UV exposure throughout the day when using.

Food

Can be taken with or without food. Some prefer with a small meal to reduce GI irritation.

Benefit Profile

🧠 Brain & Cognition
8/10
😌 Mood & Anxiety
6/10

Medical Considerations

Medical oversight strongly recommendedNot safe during pregnancy

Contraindications

  • Pregnancy/nursing
  • UV/sun exposure during use (DNA damage risk)
  • Liver disease
  • MAO inhibitor use

Drug Interactions

MAO inhibitors (9-Me-BC has MAO-inhibiting properties)Dopaminergic drugs (additive effects)Photosensitizing medications (additive phototoxicity)

Recommended Monitoring

  • Liver function tests
  • Strict UV avoidance
  • Mood and behavioral monitoring
  • Very limited human safety data

This information is for educational purposes only. Always consult a qualified healthcare provider before starting any peptide protocol.

Pricing

VendorVariantPrice
Limitless Biotech30ct 15mg$49.99BEST
Code: PSTACK10Buy

Published Research

14 studies indexed(2008–2022)2 reviews

New agents promote neuroprotection in Parkinson's disease models.

Santos CM·CNS Neurol Disord Drug Targets·2012
Review

Stimulation, protection and regeneration of dopaminergic neurons by 9-methyl-β-carboline: a new anti-Parkinson drug?

Polanski W, Reichmann H, Gille G·Expert Rev Neurother·2011
Review

Correction to: 9-Methyl-β-carboline inhibits monoamine oxidase activity and stimulates the expression of neurotrophic factors by astrocytes.

Keller S, Polanski WH, et al.·J Neural Transm (Vienna)·2022
Research Article

9-Methyl-β-carboline inhibits monoamine oxidase activity and stimulates the expression of neurotrophic factors by astrocytes.

Keller S, Polanski WH, et al.·J Neural Transm (Vienna)·2020
Research Article

Photophysical and Photochemical Properties of Naturally Occurring normelinonine F and Melinonine F Alkaloids and Structurally Related N(2)- and/or N(9)-methyl-β-carboline Derivatives.

Rasse-Suriani FAO, García-Einschlag FS, et al.·Photochem Photobiol·2018
Research Article

Mechanisms of DNA damage by photoexcited 9-methyl-β-carbolines.

Vignoni M, Rasse-Suriani FA, et al.·Org Biomol Chem·2013
Research Article

9-Methyl-β-carboline-induced cognitive enhancement is associated with elevated hippocampal dopamine levels and dendritic and synaptic proliferation.

Gruss M, Appenroth D, et al.·J Neurochem·2012
Research Article

Good guys from a shady family.

Gulyaeva N, Aniol V·J Neurochem·2012
Research Article

Inhibition of the bioactivation of the neurotoxin MPTP by antioxidants, redox agents and monoamine oxidase inhibitors.

Herraiz T, Guillén H·Food Chem Toxicol·2011
Research Article

9-Methyl-beta-carboline has restorative effects in an animal model of Parkinson's disease.

Wernicke C, Hellmann J, et al.·Pharmacol Rep·2010
Research Article
Showing 10 of 14 studies. Search PubMed for the complete list.

Stacks Well With